If you could vote on Brexit now which option would you choose?
   

Multidose COVID-19 vaccines will test state tracking systems


When the COVID-19 vaccine becomes available in the United States, officials’ first challenge is getting the people in the door for their shots. Then, they’ll have a second problem: making sure they come back again to get a second dose of the same vaccine. With two two-dose vaccines headed for authorization, the logistical challenges of a vaccination program are only magnified. “You don’t want to have someone get the first dose of one brand of vaccine, and a second dose of another,” says Ben Moscovitch, project director of health information technology at The Pew Charitable Trusts. Assuming the Food and Drug Administration authorizes the vaccines after they review the data later this month, states will start to receive shipments of the Pfizer and BioNTech vaccine on December 15th, and the Moderna vaccine on December 22nd. From there, it’s up to states to distribute the vaccines. Both take two doses, given a few weeks apart, and both could be circulating at the same time. And that’s just the two front-runners. Other multidose vaccines are still in the development pipeline.

The Verge - December 4, 2020

View the full story here: https://www.theverge.com/2020/12/4/22153908/covid-vaccine-dose-tracking-digital-registry-fda